TP63 rearrangement occurs in about 8% of Alk-negative ALCL cases and is associated with poor prognosis, with a 5-year overall survival rate of only 17%, which is lower than that of PTCL-NOS [37]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.